MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

mbp's new competitor ???????, page-2

  1. 29 Posts.
    Could be a competitor but side effects seem pronounced ie not eating! This a centrally acting compound cf metabolics. More chance of problems with other hormone systems located in the hypothalamus which the bushmen would not know of.
    They (Phizer) may to make modification to the original compound.
    Cheers
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.